Advisory Research’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,385
Closed -$319K 442
2023
Q2
$319K Buy
9,385
+2,648
+39% +$88.2K 0.04% 366
2023
Q1
$218K Buy
6,737
+406
+6% +$13.5K 0.04% 320
2022
Q4
$212K Buy
+6,331
New +$193K 0.02% 329
2022
Q3
Sell
-7,154
Closed -$249K 367
2022
Q2
$249K Sell
7,154
-12,343
-63% -$486K 0.02% 291
2022
Q1
$1.02M Buy
19,497
+4,422
+29% +$223K 0.08% 181
2021
Q4
$756K Buy
15,075
+1,540
+11% +$100K 0.06% 224
2021
Q3
$1.09M Buy
+13,535
New +$990K 0.07% 188

Other funds holding DOCS

Advisory Research's DOCS Position: Q3 2023 in Review

Advisory Research sold out of Doximity (DOCS) in Q3 2023, closing a stake of 9,385 shares — an estimated $319K sold.

Advisory Research first reported a position in DOCS in Q3 2021 and held it in 7 quarters. The position peaked at $1.09M in Q3 2021. 306 funds tracked by Wall St. Rank hold DOCS as of Q3 2023.

  • Advisory Research reported no remaining Doximity position as of Q3 2023 after selling out during the quarter.
  • Advisory Research sold 9,385 Doximity shares in Q3 2023, an estimated $319K.
  • Advisory Research first reported a position in Doximity in Q3 2021 and held it in 7 quarters.
  • Advisory Research's Doximity position peaked at $1.09M in Q3 2021.
  • 306 funds tracked by Wall St. Rank held Doximity as of Q3 2023.

Based on Advisory Research's 13F filing for Q3 2023, filed 13 Nov 2023.